QUIA — QUIA PHARMA AB (publ) Income Statement
0.000.00%
Last trade - 00:00
- SEK38.74m
- SEK36.16m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 1.86 | 0.216 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 2.41 | -2.99 | 0.527 | 3.33 | 2.17 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 18.1 | 26.8 | 17.8 | 15.8 | 15.5 |
Operating Profit | -18.1 | -24.9 | -17.6 | -15.8 | -15.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -19.6 | -27.7 | -20 | -20.1 | -16.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -19.6 | -27.7 | -20 | -20.1 | -16.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -19.6 | -27.7 | -20 | -20.1 | -16.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -19.6 | -27.7 | -20 | -20.1 | -16.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -27.6 | -42.9 | -15.8 | -5.6 | -3.35 |
Dividends per Share |